Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

2 Resultados de la búsqueda.

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Pharmacogenetic and Pharmacogenomic Research - Pharmacogenetic and Pharmacogenomic Research

- 25/9/17 - 1 formulario, 1 itemgroup, 10 items, 1 idioma

Itemgroup: PGx-Pharmacogenetic/PGm-Transcriptomic/PGM-Proteomic Research

A 24 week double-blind, randomised, placebo-controlled, parallel-group dose-ranging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer's disease.

GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)

- 31/8/17 - 1 formulario, 13 itemgroups, 59 items, 1 idioma

Itemgroups: General Information, Orthostatic Vital Signs, Baseline PLMI, Polysomnography, Baseline Inclusion Criteria, Baseline Exclusion Criteria, RLS rating scales, Vital signs, Concomitant Medication, Medical Procedures, Baseline Signs and Symptoms, Baseline Employment Status, Ramos Randomization and dispensing

Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome

Palabras clave

Tabla de contenido

Modelos de datos seleccionados

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Pharmacogenetic and Pharmacogenomic Research - Pharmacogenetic and Pharmacogenomic Research

GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)

Palabras clave

Tabla de contenido

Modelos de datos seleccionados

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Pharmacogenetic and Pharmacogenomic Research - Pharmacogenetic and Pharmacogenomic Research

GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)

Contacto

Ayuda